Here's some links to articles I wrote about my workout routine for each body part. I've been working out for 15 years now with decent success so I thikn what I have to say is quite valid.
My Weight Training Routine
How to build big Biceps
How to build big Triceps
How to build big Forearms
How to build big Shoulders
How to build a big Chest
How to build a big Back
How to build big Legs
How to build big Calves
Other workout-related advice:
Are Bowflex SelectTech Adjustable Dumbbells suitable for you?
How I lost over 40 pounds in 6 months with some simple diet changes
Friday, December 24, 2010
Thursday, December 16, 2010
Update to YRC Worldwide Fundamentals Compared to the Trucking Industry
People have been requesting an update to the numbers in my YRC Worldwide Fundamentals Compared to the Trucking Industry ranking. So here are the updates to the numbers for P/E, P/S, P/B, and Profit Margin. Debt to Capital % and Current Ratio have not changed during this time span so I will not update those items until after Q4 results. In this round it's a good news/bad news situation for YRC Worldwide. Their Book Value has gone further negative as they lost money in the last quarter, but their margin is improving and revenue has increased quarter over quarter. Refer to my original article to get commentary related to them. If there's another metric you'd like to see in this ranking, request it in the comments section and I'll see if I can dig it up the next time I do this. The companies involved in this ranking are:
Arkansas Best Corp NASDAQ:ABFS
Con-Way Inc NYSE:CNW
JB Hunt Transport Services Inc NASDAQ:JBHT
Landstar System Incorporated NASDAQ:LSTR
Old Dominion Freight Line Inc NASDAQ:ODFL
Werner Enterprises Inc NASDAQ:WERN
Price to Earnings
WERN...21.8
LSTR.....24.0
ODFL....26.9
JBHT.....27.6
Four companies have positive earnings. Not much has changed under this metric.
Price to Sales
YRCW....0.03
ABFS.......0.4
CNW........0.4
LSTR.......0.8
WERN.....0.9
ODFL......1.2
JBHT.......1.3
YRCW's P/S metric actually dropped from 0.04 to 0.03. If they can turn their margins around, they could have a very good P/E at this price.
Price to Book
ABFS.....1.5
WERN....2.1
CNW......2.2
ODFL.....2.6
LSTR......7.0
JBHT......8.1
This is where the bad side of YRC Worldwide gets worse. They have a negative book value that is getting worse. Their book value in the prior article was -$1.71. Now it's -$2.53. At that pace it could easily go to -$3 to -$4 next year.
Profit Margin
JBHT........5.02%
ODFL.......4.54%
WERN.....4.13%
LSTR.......3.43%
CNW......-0.01%
YRCW....-4.80%
ABFS.....-7.43%
The good news for YRCW is that they managed to improve their margin from -10.44% to -4.80%, making it a lot more plausible for them to start pulling a profit sometime next year as long as they keep their costs under control. A positive margin of 1% over the course of the year would cause their P/E metric to be dominant in the industry because their revenues are so much larger than their market cap when looking at the P/S.The stock price could skyrocket thanks to that. A lot of investors are betting on this happening. Meanwhile, there's a lot that look at that Book Value and see imminent bankruptcy protection written all over YRCW. It will be interesting to see where this company lands.
All numbers are updated as of December 16th, 2010. I do not own any of these companies.
Click here to learn how to trade the forex market
Back to my blog
Arkansas Best Corp NASDAQ:ABFS
Con-Way Inc NYSE:CNW
JB Hunt Transport Services Inc NASDAQ:JBHT
Landstar System Incorporated NASDAQ:LSTR
Old Dominion Freight Line Inc NASDAQ:ODFL
Werner Enterprises Inc NASDAQ:WERN
Price to Earnings
WERN...21.8
LSTR.....24.0
ODFL....26.9
JBHT.....27.6
Four companies have positive earnings. Not much has changed under this metric.
Price to Sales
YRCW....0.03
ABFS.......0.4
CNW........0.4
LSTR.......0.8
WERN.....0.9
ODFL......1.2
JBHT.......1.3
YRCW's P/S metric actually dropped from 0.04 to 0.03. If they can turn their margins around, they could have a very good P/E at this price.
Price to Book
ABFS.....1.5
WERN....2.1
CNW......2.2
ODFL.....2.6
LSTR......7.0
JBHT......8.1
This is where the bad side of YRC Worldwide gets worse. They have a negative book value that is getting worse. Their book value in the prior article was -$1.71. Now it's -$2.53. At that pace it could easily go to -$3 to -$4 next year.
Profit Margin
JBHT........5.02%
ODFL.......4.54%
WERN.....4.13%
LSTR.......3.43%
CNW......-0.01%
YRCW....-4.80%
ABFS.....-7.43%
The good news for YRCW is that they managed to improve their margin from -10.44% to -4.80%, making it a lot more plausible for them to start pulling a profit sometime next year as long as they keep their costs under control. A positive margin of 1% over the course of the year would cause their P/E metric to be dominant in the industry because their revenues are so much larger than their market cap when looking at the P/S.The stock price could skyrocket thanks to that. A lot of investors are betting on this happening. Meanwhile, there's a lot that look at that Book Value and see imminent bankruptcy protection written all over YRCW. It will be interesting to see where this company lands.
All numbers are updated as of December 16th, 2010. I do not own any of these companies.
Click here to learn how to trade the forex market
Back to my blog
Wednesday, December 15, 2010
UNG and HNU.to - A Great Place to Throw Your Money Away
Due to the cold weather and recent natgas price surge, the UNG and HNU.to longs are coming out of the closet again.There is one very strange phenomenon I've been seeing in the markets. And that is the unstoppable and undeserving popularity of HNU on the Toronto Stock Exchange. Take a look at the chart here:
Since its inception in 2008, it had 6 months of prosperity where it doubled, and since then has lost about 99.7%. Its spent about 95% of its life within 10% of its ever-decreasing lows, yet it frequently is the #1 daily volume play on the TSX with anywhere between 5M and 20M in volume a day. Now why is that? Well for one, it a 2x levered fund on the daily performance of Natural Gas.
If we go to this very useful Nat Gas streaming price link:
You'll notice 90% of people are bullish on nat gas at this price. Not to say this is a very scientific poll, but it does show that there are a ton of investors and speculators out there believing that nat gas is about to go up. Huge.
So I ask myself, ok, let's say nat gas doubles to about $8. HNU.to will go up about 4x, probably less than that unless the doubling nat gas price is literally straight up, from $6.50 to $26. However, something like Compton Petroleum would go from the 40+ cent range to I would think at least $3.50 as it would be massively profitable at $8 nat gas, nearly a 10x gain. And the downside risk in Compton is much, much less than the downside risk in HNU. CMT.to is a real company with real assets. HNU.to is some BS levered trading scam. I can only imagine what would happen to the price of Compton if it had 5M-20M a day in volume like HNU.to has.
Then you look at UNG in the States. People would rather buy that to speculate (or in their own messed up heads "invest") in natgas rather than buying a company with a ton of potential like Chesapeake or ATP.We all know China wants Chesapeake. Compton and ATP would be other things China would look at. What we know for sure though is that China does not want to buy HNU.to or UNG. What is there to buy exactly?
Its probably a lesson that many people need to learn, not just on the natgas industry but everywhere. The popularity of short funds I can understand since there's very few companies out there who's success depends on the fall of the stock market and economy. But for leveraged long funds, there is ALWAYS an industry play out there that has a better upside potential than 2x or 3x and it certainly has less downside risk than, well, -99%.
But people like to piss away their money. All their technical indicators suggest natgas is going up tomorrow so it's time to buy HNU.to! Because CMT.to might not go up that day even if natgas increases. But if they are wrong and natgas falls then their HNU.to "trade" just turned into an "investment" where they forever average down into oblivion.
Click here to see some information on three Canadian oil resource stocks with tremendous potential
Click here to learn how to trade the forex market
Back to my blog
Monday, December 13, 2010
How to Trade the Forex Market
I have been successful trading currencies over the years. Actually much more successful (lucky?) than trading stocks. The advantage to trading currencies is that you aren't really "buying" or "selling" anything. You are purely going long one currency and short another. In 2008 when all my stocks were getting creamed I had my best ever currency trading month in October. So one thing is, you can use the market to diversify. The stock market is crashing? Short Aussie dollars. It's a lot easier than trying to sell all your stocks during a market panic. Especially one that occurs when the North American markets are closed.
You can't have any Enrons in the Forex market. That being said, many people lose on the market because they treat it like the stock market. They "invest" ie buy and hold a currency (or sell and hold) on way too much margin then get a margin call if the currency moves 1% or 2% against them. 2% may not sound like much but if you are leveraging 50 to 1, that's 100% of your account.
If you are interested in trying out the forex market, I highly recommend a lot of research and practice on it first. If someone is giving away a system to follow, don't follow it, it is junk. If you want to trade on someone's system, make sure it's reputable and you have a chance to make money on it. It amazes me that people are willing to risk $10K on the forex market and lose it all, but aren't willing to spend $100 or $50 or whatever upfront money it takes along with some time and thought to actually make good money on a forex system. If you wish to purchase a good trading system, I recommend this one. They use the same broker I do and have years of experience perfecting their system.
There are also a lot of forex robots/auto-trade systems out there. Basically some computer whizzes meet with stats whizzes and they develop a system that will consistently make you money over longer periods of time - the law of large numbers just makes it like that. All of these systems are proprietary, because, well these guys probably put years of time and effort into it so they aren't going to give it away for free.The two forex program traders I like are:
The FAP Turbo Forex Robot
The Forex Morning Trade System
The man running Forex Morning Trade System says you only need to trade 10 minutes a day, but I dunno, I kind of like trading more than that in a day. That's another point though. You can't spend TOO MUCH time on forex trading. Overtrading can be your downfall as well.
Good luck on your Forex endeavors!
Back to my blog
You can't have any Enrons in the Forex market. That being said, many people lose on the market because they treat it like the stock market. They "invest" ie buy and hold a currency (or sell and hold) on way too much margin then get a margin call if the currency moves 1% or 2% against them. 2% may not sound like much but if you are leveraging 50 to 1, that's 100% of your account.
If you are interested in trying out the forex market, I highly recommend a lot of research and practice on it first. If someone is giving away a system to follow, don't follow it, it is junk. If you want to trade on someone's system, make sure it's reputable and you have a chance to make money on it. It amazes me that people are willing to risk $10K on the forex market and lose it all, but aren't willing to spend $100 or $50 or whatever upfront money it takes along with some time and thought to actually make good money on a forex system. If you wish to purchase a good trading system, I recommend this one. They use the same broker I do and have years of experience perfecting their system.
There are also a lot of forex robots/auto-trade systems out there. Basically some computer whizzes meet with stats whizzes and they develop a system that will consistently make you money over longer periods of time - the law of large numbers just makes it like that. All of these systems are proprietary, because, well these guys probably put years of time and effort into it so they aren't going to give it away for free.The two forex program traders I like are:
The FAP Turbo Forex Robot
The Forex Morning Trade System
The man running Forex Morning Trade System says you only need to trade 10 minutes a day, but I dunno, I kind of like trading more than that in a day. That's another point though. You can't spend TOO MUCH time on forex trading. Overtrading can be your downfall as well.
Good luck on your Forex endeavors!
Back to my blog
Sunday, December 12, 2010
OREX vs VVUS: How Does This Make Any Sense???
As of close on Friday, Orexigen Therapeutics has a stock price of $8.41 or a $400M market cap. Using Yahoo Finance they have a net cash position (cash less debt) of $97M. Subtracting that they have a $303M enterprise value.
VIVUS closed at $9.39 and has a $763M market value. Take away their net cash position of $143M and you are left with an enterprise value of $620M for their pipeline. One company has a drug recommended by the FDA, the other does not.
Now comparing VVUS and OREX straight up is not fair. Orexigen's got two drugs in the pipeline, but they are both obesity drugs that share some of the same compounds so really it's like they have one. Vivus' Qnexa programs are targeting Diabetes and Sleep Apnea as well so to compare the two companies we have to take the perceived market value of that portion of their pipeline out.
How can we do this? A way to try is to take a look at Arena Pharmaceuticals. Although they also have some drugs in their pipeline, the only one at a later stage is Lorcaserin so the company pretty much lives or dies off of the success of that drug. They have $177M in cash and $123M in debt so their net cash position is $54M. They have 121.4M shares outstanding. On September 13th their closing price was $6.85 a share. That's $832M in market cap, $778M in enterprise value. Once the dust settled, on September 17th they closed at $1.99, a $242M market cap and $188M enterprise value. The FDA concerns over Lorcaserin cost them 76% of their enterprise value.
Now let's look at VVUS. They have 81.2M shares. Initial reaction on their FDA non-approval caused them to drop from $12.11 on July 14th to $5.41 on July 16th. A drop from $983M to $439M in market cap or $840M in enterprise value to $296M in enterprise value. If VVUS' obesity drug lost the same 76% of its value as ARNA, it would have dropped from $717M to $173M. The value of their pipeline not related to the obesity program is 983M-717M or 439M-173M or $266M.
Going back to the start of this blog, VVUS' current enterprise value is $620M. Subtract the non-obesity part of the pipeline you're left with $354M of which the market currently thinks Qnexa Obesity is worth. That is WITHOUT any approval, just the excitement over possible approval after what happened to Orexigen.
So Orexigen's soon to be APPROVED drug Contrave is worth $303M while VVUS not yet approved Qnexa Obesity is worth $354M. I know that the data points on Qnexa are stronger, but to me an FDA approval is worth more than the data points.
If Contrave was given the same enterprise value as Qnexa of $354M, the market value of OREX would be $354M+$97M= $451M. with 47.58M shares outstanding, that's a $9.48 share price. If Contrave is worth 25% more (I think that's a fair assumption of where they should be given the relative state of each drug) that's $443M in Contrave and $540M in market cap, $11.35 share price. Assuming 50% more value over Qnexa, and the stock price is $13.20. You get the point. I think OREX is hugely undervalued right now when looking at VVUS.
Then you think about ARNA and how before the FDA concerns it was trading at a $832M market cap with $43M less in the bank than OREX. A market cap of $875M for OREX leaves it with a stock price of $18.39.
Take a look at what I think about ARNA and ETRM
Click here to learn how to trade the forex market
Back to my blog
VIVUS closed at $9.39 and has a $763M market value. Take away their net cash position of $143M and you are left with an enterprise value of $620M for their pipeline. One company has a drug recommended by the FDA, the other does not.
Now comparing VVUS and OREX straight up is not fair. Orexigen's got two drugs in the pipeline, but they are both obesity drugs that share some of the same compounds so really it's like they have one. Vivus' Qnexa programs are targeting Diabetes and Sleep Apnea as well so to compare the two companies we have to take the perceived market value of that portion of their pipeline out.
How can we do this? A way to try is to take a look at Arena Pharmaceuticals. Although they also have some drugs in their pipeline, the only one at a later stage is Lorcaserin so the company pretty much lives or dies off of the success of that drug. They have $177M in cash and $123M in debt so their net cash position is $54M. They have 121.4M shares outstanding. On September 13th their closing price was $6.85 a share. That's $832M in market cap, $778M in enterprise value. Once the dust settled, on September 17th they closed at $1.99, a $242M market cap and $188M enterprise value. The FDA concerns over Lorcaserin cost them 76% of their enterprise value.
Now let's look at VVUS. They have 81.2M shares. Initial reaction on their FDA non-approval caused them to drop from $12.11 on July 14th to $5.41 on July 16th. A drop from $983M to $439M in market cap or $840M in enterprise value to $296M in enterprise value. If VVUS' obesity drug lost the same 76% of its value as ARNA, it would have dropped from $717M to $173M. The value of their pipeline not related to the obesity program is 983M-717M or 439M-173M or $266M.
Going back to the start of this blog, VVUS' current enterprise value is $620M. Subtract the non-obesity part of the pipeline you're left with $354M of which the market currently thinks Qnexa Obesity is worth. That is WITHOUT any approval, just the excitement over possible approval after what happened to Orexigen.
So Orexigen's soon to be APPROVED drug Contrave is worth $303M while VVUS not yet approved Qnexa Obesity is worth $354M. I know that the data points on Qnexa are stronger, but to me an FDA approval is worth more than the data points.
If Contrave was given the same enterprise value as Qnexa of $354M, the market value of OREX would be $354M+$97M= $451M. with 47.58M shares outstanding, that's a $9.48 share price. If Contrave is worth 25% more (I think that's a fair assumption of where they should be given the relative state of each drug) that's $443M in Contrave and $540M in market cap, $11.35 share price. Assuming 50% more value over Qnexa, and the stock price is $13.20. You get the point. I think OREX is hugely undervalued right now when looking at VVUS.
Then you think about ARNA and how before the FDA concerns it was trading at a $832M market cap with $43M less in the bank than OREX. A market cap of $875M for OREX leaves it with a stock price of $18.39.
Take a look at what I think about ARNA and ETRM
Click here to learn how to trade the forex market
Back to my blog
Friday, December 10, 2010
Update to Key Fundamental Statistics for US Banks
Many people have been requesting an update to the numbers in my Key Fundamental Statistics for US Banks ranking. So here are the updates to the numbers for P/E, P/S, P/B, Profit Margin and Dividend yield. The numbers in the original article were after each company's Q3 results so the margins remain the same but these numbers do reflect most recent stock prices so I can understand why people would want to refer to updates. Refer to my original article to get commentary related to them.If there's another metric you'd like to see in this ranking, request it in the comments section and I'll see if I can dig it up the next time I do this. The companies involved in this ranking are:
Bank of America Corp NYSE:BAC
BB&T Corporation NYSE:BBT
Capital One Financial Corporation NYSE:COF
Citigroup Inc NYSE:C
Fifth Third Bancorp NASDAQ:FITB
JPMorgan Chase and Co NYSE:JPM
PNC Financial Services Group Inc NYSE:PNC
Regions Financial Corp NYSE:RF
Suntrust Banks Incorporated NYSE:STI
US Bancorp NYSE:USB
Wells Fargo & Company NYSE:WFC
Price to Earnings
COF….......6.7
PNC.........10.6
JPM.........11.2
USB.........16.3
WFC….....17.5
BBT..........22.6
Industry...30.5
FITB.......163.0
Again, using this metric, COF dominates. PNC and JPM would be the only other two to be seriously considered using the P/E. Every Canadian bank does better than the rest of the US banks so I would lean in that direction if I were a bank investor. C, BAC, STI and RF are all negative and thus aren't ranked.
Price to Sales
Nothing much to say here other than at least we can see where C, BAC, RF and STI rank because they can't go to negative sales. BAC actually does rather well using the price to sales metric.
Price to Book
My personal favourite, BAC leads this list again. Nice to see that if it has a ton of toxic assets on its balance sheet, at least people are paying 60 cents on the dollar for them. To be honest, BAC does do pretty well relative to C. COF is near the top of the list here too, impressive since it's at least earning money the "accounting" way.
Profit Margin
Not much to say here, other than the usual suspects round out the bottom and the more decent plays are at the top. Wouldn't mind seeing that JPM number AFTER they are forced to liquidate their silver shorts.
Dividend Yield %
That's not a typo, every US bank pays a lower dividend than the banking industry worldwide. It's those blasted Canadian companies and their 3-5% dividends!!! You can tell I am pushing them hard right? If you're interested in a report that lists the top 100 dividend companies, see my blog on it. It's a $19 subscription service, just warning you before you click on the link and become disappointed in me. I find it useful and it costs about the same as commission on 3 trades. If I'm going to advertise, it's not going to be on crap.
All numbers are updated as of December 9th, 2010. I do not own any of these companies, probably for a pretty good reason!
Click here to learn how to trade the forex market
Back to my blog
Bank of America Corp NYSE:BAC
BB&T Corporation NYSE:BBT
Capital One Financial Corporation NYSE:COF
Citigroup Inc NYSE:C
Fifth Third Bancorp NASDAQ:FITB
JPMorgan Chase and Co NYSE:JPM
PNC Financial Services Group Inc NYSE:PNC
Regions Financial Corp NYSE:RF
Suntrust Banks Incorporated NYSE:STI
US Bancorp NYSE:USB
Wells Fargo & Company NYSE:WFC
Price to Earnings
COF….......6.7
PNC.........10.6
JPM.........11.2
USB.........16.3
WFC….....17.5
BBT..........22.6
Industry...30.5
FITB.......163.0
Again, using this metric, COF dominates. PNC and JPM would be the only other two to be seriously considered using the P/E. Every Canadian bank does better than the rest of the US banks so I would lean in that direction if I were a bank investor. C, BAC, STI and RF are all negative and thus aren't ranked.
Price to Sales
| BAC.........1.1 |
| COF……...1.2 |
| RF…….....1.2 |
| JPM….…..1.6 |
| STI…...…..1.6 |
| WFC….....1.8 |
| FITB……...1.8 |
| C……...….1.8 |
| BBT….…..1.9 |
| PNC….…..2.0 |
| Industry…2.4 |
| USB……..2.7 |
Nothing much to say here other than at least we can see where C, BAC, RF and STI rank because they can't go to negative sales. BAC actually does rather well using the price to sales metric.
Price to Book
| BAC……...0.6 |
| RF…...…..0.6 |
| COF……...0.7 |
| STI…...…..0.7 |
| C……...….0.8 |
| JPM……...1.0 |
| FITB….…..1.1 |
| BBT……....1.1 |
| PNC……...1.1 |
| WFC……..1.3 |
| Industry…1.3 |
| USB……..1.8 |
My personal favourite, BAC leads this list again. Nice to see that if it has a ton of toxic assets on its balance sheet, at least people are paying 60 cents on the dollar for them. To be honest, BAC does do pretty well relative to C. COF is near the top of the list here too, impressive since it's at least earning money the "accounting" way.
Profit Margin
| PNC……...20.47% |
| COF……...17.68% |
| USB….…..16.54% |
| JPM……...15.86% |
| Industry…14.76% |
| WFC …....14.10% |
| BBT…….....8.96% |
| FITB……....5.12% |
| C……...…..2.50% |
| BAC……...-1.05% |
| STI…….....-2.83% |
| RF……....-18.18% |
Not much to say here, other than the usual suspects round out the bottom and the more decent plays are at the top. Wouldn't mind seeing that JPM number AFTER they are forced to liquidate their silver shorts.
Dividend Yield %
| Industry…2.45% |
| BBT……...2.43% |
| USB……...0.82% |
| WFC……..0.70% |
| PNC…......0.69% |
| RF…….....0.67% |
| COF….…..0.52% |
| JPM….…..0.51% |
| BAC……..0.35% |
| FITB……..0.31% |
| STI……....0.16% |
| C……..….0.00% |
That's not a typo, every US bank pays a lower dividend than the banking industry worldwide. It's those blasted Canadian companies and their 3-5% dividends!!! You can tell I am pushing them hard right? If you're interested in a report that lists the top 100 dividend companies, see my blog on it. It's a $19 subscription service, just warning you before you click on the link and become disappointed in me. I find it useful and it costs about the same as commission on 3 trades. If I'm going to advertise, it's not going to be on crap.
All numbers are updated as of December 9th, 2010. I do not own any of these companies, probably for a pretty good reason!
Click here to learn how to trade the forex market
Back to my blog
Wednesday, December 8, 2010
Do not let go of your OREX shares!!!
In case you haven't heard, Orexigen Therapeutics is up over 100% today on approval of its diet drug Contrave. Its hard to gauge an exact worth of a company after something like this has been done so I always look for previous examples and try to guess what will happen from there. The most similar case to OREX was what happened to DNDN in March 2007. Now check out these price histories on the stock:
After a strong open on March 30th, the stock ended rather weakly. But within a few days the stock recovered to its prior high and went as high as $25 by April 25th. It came back down to earth after that, but that just goes to show you that the time to sell your OREX shares is not today, it's a couple weeks from now. Let those shorties burn a bit!!! No matter how weak the stock price gets, hold on. DNDN dropped from $18 to $12 so there were a lot of weak handed day traders that lost 30% that day who could have gained 30% if they were two-week traders.
ARNA and ETRM are also being pulled up by OREX today. You can read my bullish blog article here.
Back to my blog
| Date | Open | High | Low | Close | Volume | Adj Close* |
|---|---|---|---|---|---|---|
| Apr 10, 2007 | 24.85 | 25.25 | 20.26 | 22.15 | 66,675,000 | 22.15 |
| Apr 9, 2007 | 20.00 | 24.27 | 19.86 | 23.58 | 78,665,100 | 23.58 |
| Apr 5, 2007 | 15.10 | 18.28 | 14.84 | 18.05 | 60,174,800 | 18.05 |
| Apr 4, 2007 | 15.00 | 15.15 | 14.66 | 15.08 | 13,677,800 | 15.08 |
| Apr 3, 2007 | 14.47 | 15.40 | 14.47 | 14.65 | 25,813,600 | 14.65 |
| Apr 2, 2007 | 13.25 | 14.99 | 13.10 | 14.30 | 43,706,300 | 14.30 |
| Mar 30, 2007 | 17.92 | 18.05 | 12.00 | 12.93 | 92,499,200 | 12.93 |
| Mar 29, 2007 | 5.22 | 5.22 | 5.22 | 5.22 | 0 | 5.22 |
| Mar 28, 2007 | 4.85 | 5.34 | 4.48 | 5.22 | 32,840,900 | 5.22 |
After a strong open on March 30th, the stock ended rather weakly. But within a few days the stock recovered to its prior high and went as high as $25 by April 25th. It came back down to earth after that, but that just goes to show you that the time to sell your OREX shares is not today, it's a couple weeks from now. Let those shorties burn a bit!!! No matter how weak the stock price gets, hold on. DNDN dropped from $18 to $12 so there were a lot of weak handed day traders that lost 30% that day who could have gained 30% if they were two-week traders.
ARNA and ETRM are also being pulled up by OREX today. You can read my bullish blog article here.
Back to my blog
Subscribe to:
Posts (Atom)